Elizabeth A Guancial

3PUBLICATIONS
16CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 03, 2025
IK-175, an Oral Aryl Hydrocarbon Receptor Inhibitor, Alone and with Nivolumab in Patients with Advanced Solid Tumors and Urothelial Carcinoma.

David H Aggen, Meredith McKean, Jean H Hoffman-Censits

|May 18, 2016
Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.

Elizabeth A Guancial, Deepak Kilari, Guang-Qian Xiao

|Feb 28, 2015
HER2 as a target in invasive urothelial carcinoma.

Joaquim Bellmunt, Lillian Werner, Aristotle Bamias

Pageof 1

Frequent Collaborators

1 joint publications

David H Aggen

1 joint publications

Meredith McKean

1 joint publications

Jean H Hoffman-Censits

1 joint publications

Nehal J Lakhani